مقایسه اختلالات جنسی بین مصرف کنندگان بوپرونورفین و اپیوم

Ahmadi, J., Mansoori, A., Mosavat, S. H., & Bazrafshan, A. (2024). Comparison of ketamine with buprenorphine as adjunctive therapy in the treatment of comorbid major depressive disorder and opium use disorders: A randomized controlled trial. The International Journal of Psychiatry in Medicine, 59(5), 521-535.

Ahmadvand, A., Mansournejad, M., & Sepehrmanesh, Z. (2023). Evaluation of the sexual performance in male drug abusers under treatment with methadone and buprenorphine in 2021. Feyz Medical Sciences Journal, 27(1), 90-96.

Bahadori, Z., Safaie, N., & Mirmohammadkhani, M. (2022). Comparison of psychiatric disorders in addicted patients treated with buprenorphine, methadone, and opium tincture in Iran. Middle East Current Psychiatry, 29(1), 60. https://doi.org/10.1186/s43045-022-00224-x

Chawla, N., Verma, S., Ganesh, R., Sarkar, S., & Ambekar, A. (2021). Sexual relationship, self-esteem, dysfunction, and sexual satisfaction in treatment naïve men with heroin dependence. Journal of Psychoactive Drugs, 53(4), 364-372.

Datta, A. (2018). Effect of Naltrexone and Buprenorphine-Naloxone on Sexual Function and Bone Mineral Density in Patients with Opioid Dependence Syndrome: A Comparative Study Central Institute of Psychiatry (India)].

Farnia, V., Tatari, F., Alikhani, M., Shakeri, J., Taghizadeh, M., Karbasizadeh, H., Sadeghi Bahmani, D., Holsboer-Trachsler, E., & Brand, S. (2017). Rosa Damascena oil improved sexual function and testosterone in male patients with opium use disorder under methadone maintenance therapy–results from a double-blind, randomized, placebo-controlled clinical trial. Drug and Alcohol Dependence, 176, 117-125. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2017.02.008

Fazeli, A., & Pourmahmodian, M. (2019). A comparative study of maintenance therapy effects of methadone, buprenorphine and opium tincture on sleep status of outpatients referring to addiction treatment centers in Tehran: A prospective study. Pakistan Journal of Medical and Health Sciences, 13(3), 876-880.

Haddadi, M., Rahimi-Movaghar, A., Farrahi, F., & Farahmandfar, M. (2019). Comparison of the effects of methadone with buprenorphine on reproductive (sexual) hormone profile and seminal fluid analysis (fertility) in men on maintenance treatment. Clinical Excellence, 9(1), 48-60.

Kheradmand, A., Fazeli, A., & Meybodi, A. M. (2019). Comparing the effects of methadone, buprenorphine, and opium tincture maintenance therapy on sexual function. Addiction & Health, 11(2), 120.

Mattoo, S. K., Ghosh, A., Subodh, B., Basu, D., Satapathy, A., Prasad, S., & Sharma, M. P. (2020). Sexual dysfunction in men on buprenorphine–naloxone-based substitution therapy. Indian Journal of Psychiatry, 62(1), 66-72.

Pirnia, B., Masoudi, R., Pirnia, K., Jalali, M., Eslami, M. R., Malekanmehr, P., Pirnia, F., & Ajori, L. (2020). Effect of Magnesium Sulfate Added to Tincture of Opium and Buprenorphine on Pain and Quality of Life in Women with Dysmenorrhea: A Prospective, Randomized, Double-blind, Placebo-controlled Trial. Addiction & Health, 12(4), 259.

Ramdurg, S., Ambekar, A., & Lal, R. (2015). Co-relationship between sexual dysfunction and high-risk sexual behavior in patients receiving buprenorphine and naltrexone maintenance therapy for opioid dependence. Industrial Psychiatry Journal, 24(1). https://journals.lww.com/inpj/fulltext/2015/24010/co_relationship_between_sexual_dysfunction_and.6.aspx

Ramli, F. F., Azizi, M. H., & Syed Hashim, S. A. (2021). Treatments of Sexual Dysfunction in Opioid Substitution Therapy Patients: A Systematic Review and Meta-Analysis. Int J Med Sci, 18(11), 2372-2380. https://doi.org/10.7150/ijms.57641

Salata, B., Kluczna, A., & Dzierżanowski, T. (2022). Opioid-induced sexual dysfunction in cancer patients. Cancers, 14(16), 4046.

Sen, M. S., Chattopadhyay, A., Chawla, N., Ganesh, R., Verma, S., Sarkar, S., & Ambekar, A. (2023). A comparative study of sexual behavior, dysfunction, satisfaction, relationship, and sexual quality of life amongst treatment-naïve and abstinent men (buprenorphine-maintained) with Opioid (heroin) dependence syndrome. Indian Journal of Psychiatry, 65(1), 75-82.

Shahzadi, M., Naseem, T., Unbrin, A., & Hussain, A. (2023). Association Between Opioid Use and Risk of Sexual Dysfunction: A Systematic Review. Pakistan Journal of Humanities and Social Sciences, 11(2), 1879–1888. https://doi.org/10.52131/pjhss.2023.1102.0489

Shava, E., Lipira, L. E., Beauchamp, G. G., Donnell, D. J., Lockman, S., Ruan, Y., & Shao, Y. (2018). Risky sexual behavior among individuals receiving buprenorphine/naloxone opiate dependency treatment: HIV prevention trials network (HPTN) 058. JAIDS Journal of Acquired Immune Deficiency Syndromes, 78(3), 300-307.

Xu, P., Choi, E., El-Khatib, F. M., Choe, E., & Yafi, F. (2020). Sexual dysfunction in persons receiving opioid substitution therapy. Current Sexual Health Reports, 12, 371-380.

Yee, A., Loh, H. S., Loh, H. H., Riahi, S., Ng, C. G., & Sulaiman, A. H. b. (2019). A comparison of sexual desire in opiate-dependent men receiving methadone and buprenorphine maintenance treatment. Annals of General Psychiatry, 18, 1-8.